Contribution of TIP30 to chemoresistance in laryngeal carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Laryngeal squamous cell carcinoma (LSCC) survival rates have stagnated despite treatment advances.
• TIP30, a tumor suppressor, plays a role in tumor development.
• The function of TIP30 in LSCC chemoresistance remains largely unexplored.

Purpose of the Study:

• To investigate the role of TIP30 in the chemoresistance of LSCC.
• To explore the underlying molecular mechanisms of TIP30's function in LSCC.
• To evaluate TIP30 as a potential therapeutic target for LSCC.

Main Methods:

• In vitro and in vivo experiments using laryngeal carcinoma cells and xenografts.
• Analysis of TIP30 expression in drug-selected cells (DSCs).
• Investigation of TIP30's effect on cell proliferation, self-renewal, and chemoresistance.
• Exploration of the role of β-catenin nuclear localization and the AKT/GSK-3β/β-catenin pathway.

Main Results:

• TIP30 expression was significantly decreased in LSCC drug-selected cells.
• Reduced TIP30 expression enhanced chemoresistance, proliferation, and self-renewal.
• Overexpression of TIP30 in DSCs decreased self-renewal capacity and chemoresistance.
• TIP30 negatively regulated tumor growth and chemoresistance in vivo.
• Decreased TIP30 expression promoted LSCC chemoresistance and proliferation via β-catenin nuclear localization.
• Low TIP30 expression independently predicted poor survival in LSCC patients.

Conclusions:

• TIP30 plays a critical role in regulating chemoresistance and tumor progression in LSCC.
• The AKT/glycogen synthase kinase-3β/β-catenin signaling pathway is involved in TIP30's mechanism of action.
• TIP30 is a potential therapeutic target for improving chemotherapy efficacy in LSCC.